Raymond James & Associates’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-23
Closed -$215K 1985
2013
Q2
$215K Buy
+23
New +$215K ﹤0.01% 1821